Age, GFR, and Ejection Fraction Score as a Good Predictor of Prognosis in Elderly Patients with Nonischemic Dilated

Xinyi Li1, Anhong Huang2, Xiaonan Zhang1

  • 1Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.

Gerontology
|December 28, 2022
PubMed

Insights

The new AGEF score effectively predicts mortality in elderly patients with nonischemic dilated cardiomyopathy (NIDCM). A score of 2.50 or lower indicates a better long-term prognosis, simplifying risk assessment.

Area of Science:

  • Cardiology
  • Medical Prognostics
  • Geriatric Medicine

Background:

  • Nonischemic dilated cardiomyopathy (NIDCM) presents a significant risk of sudden cardiac death, even with treatment.
  • Existing predictive scores like Selvester QRS and ESTIMATED are complex and have many variables.
  • A simpler, accurate prognostic tool is needed for clinical practice in NIDCM patients.

Purpose of the Study:

  • To develop and validate a simple predictive score for assessing prognosis in elderly patients with NIDCM.
  • To evaluate the efficacy of the AGEF score in predicting in-hospital and long-term mortality.

Main Methods:

  • A cohort of 953 elderly patients (age ≥60) with NIDCM was studied retrospectively (January 2010 - December 2019).
  • Statistical analyses included univariate logistic regression, receiver operator characteristic (ROC) curve analysis, Kaplan-Meier survival analysis, and multivariate Cox proportional hazard analysis.
  • The AGEF score's predictive performance for in-hospital and long-term outcomes was assessed.

Main Results:

  • The AGEF score was significantly associated with in-hospital mortality (OR: 1.828, p < 0.001).
  • ROC analysis demonstrated the AGEF score's excellent predictive capability for clinical outcomes (AUC = 0.743, p < 0.001).
  • An AGEF score ≤2.50 was identified as optimal for predicting better long-term survival (HR: 0.405, p < 0.001), indicating a lower risk of mortality.

Conclusions:

  • The AGEF score serves as a simple and effective tool for risk stratification in elderly NIDCM patients.
  • This score can aid clinicians in assessing prognosis and guiding treatment decisions.
  • Further validation in diverse populations may enhance its clinical utility.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
25
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
23
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25